DiviDrip · FTXH

FTXH — First Trust Nasdaq Pharmaceuticals ETF

FTXH is First Trust's First Trust Nasdaq Pharmaceuticals ETF (Healthcare). Trading at $34.87. Current dividend yield: 1.24%.

Dividend snapshot

Annual dividend rate$0.42
Current yield1.24%
Payment frequencyQuarterly
Next ex-dividend dateJun 26, 2026
Most recent payment dateMar 26, 2026
Last payment amount$0.0573
5-year dividend CAGR16.86%
3-year dividend CAGR15.10%
Expense ratio0.60%
Payout ratio0%
Market cap$32M
ExchangeNGM

Recent dividend payments

DateAmount / share
2026-03-26$0.0570
2025-12-12$0.1290
2025-09-25$0.1450
2025-06-26$0.0890
2025-03-27$0.0990
2024-12-13$0.1300
2024-09-26$0.1220
2024-06-27$0.1280

About FTXH

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.

Track FTXH in DiviDrip

Add FTXH to your portfolio on DiviDrip to track every buy, DRIP reinvestment, and dividend payment in one place. Free, no credit card, no upsell — built by dividend investors, for dividend investors.

Data refreshed 2026-05-23. Not investment advice. Yields and prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow

Made with Emergent